André Zapun, Claude A Jakob, David Y Thomas, John JM Bergeron 

Slides:



Advertisements
Similar presentations
Protein sorting and the Golgi apparatus
Advertisements

Cell and Molecular Biology Behrouz Mahmoudi Cell Organelles-1 1.
Posttranslational modification, folding, assembly, and death 1.Covalent modifications 1)Proteolytic processing: posttranslational processing is called.
Lorna Pierce. To generate free oligosaccharides characteristic of protein misfolding due to treatment with NB-DNJ To observe the effect of endomannosidase.
Lecture 2: Protein sorting (endoplasmic reticulum) Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of Genetics.
Imino sugars and perturbation of protein folding pathways in the ER Dom Alonzi.
The Biological Activity of a Novel Photoaffinity- Labelled Imino Sugar Jane Atkin St. Hilda’s College.
Chapter 3 Membrane targeting of proteins By D. Thomas Rutkowski & Vishwanath R. Lingappa.
Protein Processing in the Endoplasmic Reticulum Phyllis Hanson Cell Biology Dept., Cancer Res Bldg /8/15.
ER stress and disease. introduction ER function: an organelle where secretory or membrane proteins are synthesized. ----Nascent proteins are folding with.
Molecular Biology of the Cell
Protein targeting or Protein sorting Refer Page 1068 to 1074 Principles of Biochemistry by Lehninger & Page 663 Baltimore Mol Cell Biology.
Protein Folding BL
Antigen Processing and Presentation
Intracellular Compartments and Protein Sorting
Protein Processing in the Endoplasmic Reticulum
Complex Carbohydrate Research Center
Intracellular Vesicular Traffic
Intracellular Vesicular Traffic
Diversity of Polyubiquitin Chains
Volume 52, Issue 3, Pages (March 2010)
Molecular chaperones: Pathways and networks
The Back and Forth of Cargo Exit from the Endoplasmic Reticulum
Protein Synthesis and Transport within the Cell
Liver – master and servant of serum proteome
ATP Consumption Promotes Cancer Metabolism
Volume 8, Issue 3, Pages (September 2001)
Volume 40, Issue 6, Pages (December 2010)
Figure 1 ER stress and associated lines of defence
by W. Beau Mitchell, JiHong Li, Deborah L. French, and Barry S. Coller
Volume 20, Issue 4, Pages (November 2005)
How Are Proteins Reduced in the Endoplasmic Reticulum?
Protein Origami for Beginners
Fucose Is on the TRAIL of Colon Cancer
Meindert Lamers, Ilana Berlin, Jacques Neefjes  Current Biology 
Peroxisomal Protein Import
Volume 84, Issue 1, Pages (July 2013)
Hudson H. Freeze, Jessica X. Chong, Michael J. Bamshad, Bobby G. Ng 
Volume 28, Issue 5, Pages (November 2015)
Cystic Fibrosis as a Disease of Misprocessing of the Cystic Fibrosis Transmembrane Conductance Regulator Glycoprotein  John R. Riordan  The American Journal.
More Than One Glycan Is Needed for ER Glucosidase II to Allow Entry of Glycoproteins into the Calnexin/Calreticulin Cycle  Paola Deprez, Matthias Gautschi,
Neuronal Aggregates: Formation, Clearance, and Spreading
Endoplasmic reticulum stress in proteinuric kidney disease
Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders  Giancarlo.
Protein Turnover: A CHIP Programmed for Proteolysis
Minor histocompatibility antigens in human stem cell transplantation
Unfolded protein response
Volume 88, Issue 1, Pages (January 1997)
Alexander Buchberger, Bernd Bukau, Thomas Sommer  Molecular Cell 
Glycoprotein degradation: Do sugars hold the key?
Importing Mitochondrial Proteins: Machineries and Mechanisms
Volume 13, Issue 1, Pages (January 2004)
Protein Translocons Cell
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Calnexin Discriminates between Protein Conformational States and Functions as a Molecular Chaperone In Vitro  Yoshito Ihara, Myrna F Cohen-Doyle, Yoshiro.
Pathogenic Hijacking of ER-Associated Degradation: Is ERAD Flexible?
Division of Labor by Dendritic Cells
Major histocompatibility complex
N-glycan processing in the CNX cycle.
Volume 57, Issue 3, Pages (March 2000)
Guardians of the ERAD Galaxy
A Futile Battle? Protein Quality Control and the Stress of Aging
Orchestration of the immune response by dendritic cells
Protein regulation: Tag wrestling with relatives of ubiquitin
Markus Böhm, Thomas A. Luger, Desmond J
Design Principles of Protein Biosynthesis-Coupled Quality Control
Yuki Okuda-Shimizu, Linda M. Hendershot  Molecular Cell 
Tatiana Soldà, Carmela Galli, Randal J. Kaufman, Maurizio Molinari 
Secretory kinase Fam20C tunes endoplasmic reticulum redox state via phosphorylation of Ero1α mRNA levels of several ER folding catalysts and Fam20 family.
Novel pharmacological strategies to treat cystic fibrosis
Presentation transcript:

Protein folding in a specialized compartment: the endoplasmic reticulum  André Zapun, Claude A Jakob, David Y Thomas, John JM Bergeron  Structure  Volume 7, Issue 8, Pages R173-R182 (August 1999) DOI: 10.1016/S0969-2126(99)80112-9

Figure 1 The cooperation of ERp57 and calnexin to catalyze disulfide-bond formation and rearrangements in glycoproteins. The catalytic activity of the disulfide isomerase ERp57 is greater on monoglucosylated glycoproteins in the presence of calnexin. ERp57 does not recognize the substrate directly, but associates dynamically with calnexin (CNX). (This figure was reproduced from [54] with permission.) Structure 1999 7, R173-R182DOI: (10.1016/S0969-2126(99)80112-9)

Figure 2 Model for ER quality control suggested by Hammond, Braakman and Helenius [68]. During the calnexin cycle, newly synthesized glycoproteins are de-glucosylated by the sequential actions of glucosidase I (GLSI) and II (GLSII), making a monoglucosylated protein available for binding to the lectin-like chaperones calnexin and calreticulin (CNX/CRT). Upon dissociation, glucosidase II removes the last glucose residue wherein the protein, if incompletely folded, is subjected to a further round of monoglucosylation by UDP-glucose:glycoprotein glucosyltransferase (UGGT). If fully folded, the glycoprotein is not recognized by UGGT and is allowed to leave the ER (export). Glucose residues in newly synthesized glycoproteins are indicated (G, blue). The pink triangles represent the core oligosaccharide, Man9GlcNAc2. Structure 1999 7, R173-R182DOI: (10.1016/S0969-2126(99)80112-9)

Figure 3 Extended model for quality control of glycoprotein folding and degradation in mammalian cells. Unfolded or misfolded glycoproteins are subject to folding by chaperones, re-glucosylation by UGGT, retention by calnexin/calreticulin (CNX/CRT) and de-glucosylation by glucosidase II (GLSII). Correctly folded proteins are recognized and exit the ER to subsequent compartments. Upon prolonged presence in the folding environment of the ER, ER-luminal mannosidases (MNS1) further trim mannose residues of the N-linked oligosaccharide in order to generate a degradation signal. This degradation signal is presumably recognized by a receptor with lectin-like properties and targets the glycoprotein to retrotranslocation and degradation by the ubiquitin-proteasome pathway in the cytoplasm. Glucose residues (G) are shown as blue spheres and core oligosaccharides as pink triangles. Structure 1999 7, R173-R182DOI: (10.1016/S0969-2126(99)80112-9)

Figure 4 Model for the quality control of glycoprotein folding in S. cerevisiae. As opposed to other eukaryotic systems, the system appears to be a linear pathway. Correctly folded proteins can exit the ER even before the N-linked oligosaccharides are completely trimmed. Misfolded glycoproteins remain in the ER lumen and are completely trimmed by glucosidase II (GLSII) and mannosidase 1 (MNS1). The Man8GlcNAc2 oligosaccharide in conjunction with an associated chaperone (e.g. Kar2p) forms the degradation signal. A receptor with lectin-like properties directs the misfolded protein to retrotranslocation and degradation by the ubiquitin-proteasome pathway in the cytoplasm. N-acetylglucosamine residues (black rectangles), mannose residues (white rectangles) and glucose residues (G, blue) in newly synthesized glycoproteins are indicated. An associated chaperone (e.g. Kar2p) is indicated by the red oval. Structure 1999 7, R173-R182DOI: (10.1016/S0969-2126(99)80112-9)